Level of risk peaked in the week after a hospital admission but lingered through 6 months ...

The implantable blood pressure sensor will now be available to patients with chronic heart failure through the NHS.

Learn about surgical options for hypertrophic cardiomyopathy (HCM), including septal myectomy, septal ablation, and heart ...

A newly developed fine-grained framework assesses transthoracic echocardiography image quality, revealing significant ...

Around 64 million people worldwide suffer from heart failure, and nearly half die within the first five years of diagnosis ...

Atrial fibrillation, or A-fib, is becoming more common, but doctors say treatments are improving. The condition is a ...

Alex Balmes thought it was anxiety causing his symptoms, but it was heart failure at 30. Here's what this young dad wants ...

Adults hospitalized with RSV-associated ARI faced persistent long-term adverse outcomes when compared with those with influenza-associated ARI or no recent ARI.

HCM is a genetic disease, usually caused by mutations in sarcomere proteins such as myosin, actin, tropomyosin, and myosin-binding protein C.

Two types of implantable cardioverter defibrillators can reduce the risk of sudden cardiac death with HCM. Pacemakers and implantable loop recorders also may be options.

A machine learning model incorporating functional assessments predicts one-year mortality in older patients with HF and improves risk stratification beyond established scores. Functional status at ...